The Dicey Role of Dicer: Implications for RNAi Therapy
Authors:
Open Access
- 31 March 2010
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (7) , 2571-2574
Abstract
The dynamic properties of RNA interference (RNAi) in cancer biology have led investigators to pursue with significant interest its role in tumorigenesis and cancer therapy. We recently reported that decreased expression of key RNAi enzymes, Dicer and Drosha, in epithelial ovarian cancers was associated with poor clinical outcome in patients. Dicer expression was also functionally relevant in that targeted silencing was limited with RNAi fragments that require Dicer function compared with those that do not. Together, this and other studies suggest that RNAi machinery expression may affect key pathways in tumorigenesis and cancer biology. Understanding alterations in the functional RNAi machinery is of fundamental importance as we strive to develop novel therapies using RNAi strategies. Cancer Res; 70(7); 2571–4Keywords
This publication has 32 references indexed in Scilit:
- Dicer, Drosha, and Outcomes in Patients with Ovarian CancerNew England Journal of Medicine, 2008
- MicroRNAs and cancer: An overviewCell Cycle, 2008
- Strategies for silencing human disease using RNA interferenceNature Reviews Genetics, 2007
- A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenesOncogene, 2006
- Focal Adhesion Kinase Targeting UsingIn vivoShort Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma TherapyClinical Cancer Research, 2006
- RAS Is Regulated by the let-7 MicroRNA FamilyCell, 2005
- Reduced expression of Dicer associated with poor prognosis in lung cancer patientsCancer Science, 2005
- Adeno-Associated Virus Vectors for Short Hairpin RNA Expression2005
- RNA interferenceNature, 2002
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998